GR990100331A - Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses - Google Patents

Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses

Info

Publication number
GR990100331A
GR990100331A GR990100331A GR990100331A GR990100331A GR 990100331 A GR990100331 A GR 990100331A GR 990100331 A GR990100331 A GR 990100331A GR 990100331 A GR990100331 A GR 990100331A GR 990100331 A GR990100331 A GR 990100331A
Authority
GR
Greece
Prior art keywords
cells
genetic
amniotic
embryo
human
Prior art date
Application number
GR990100331A
Other languages
Greek (el)
Other versions
GR1004204B (en
Inventor
Original Assignee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by filed Critical
Publication of GR990100331A publication Critical patent/GR990100331A/en
Publication of GR1004204B publication Critical patent/GR1004204B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly

Abstract

This invenion belongs to the field of biotechnology, cryobiology and human therapeutics. Object of the invention are a) amniotic cells originating from amniotic fluid that surrounds the embryo in its early development stages, b) amniotic cells that at early embryonic stage are floating within the human embryo-clone, c) every biological material which will be created directly of idirectly from the above amniotic cells, as well as every biological product or byproduct which will be the outcome of the use of the said cryopreserved amniotic cells, through their reproduction on multiplication under the same or any other modified form and which will possess the same genetic properties and applications.These amniotic cells are isolated from their natural environment and preserved in deep-freezing for very long periods of time after their own natural life span, which is short within their natural environment, that is within the amniotic fluid and within the embryo-clone. The purpose is the genetic and medical use of these cells at a time posterior to their natural destruction. In this way, we succeed to use primal, undifferentiated, genetically identical cells of each human being for diagnosis and therapy of genetic or non-genetic diseases, malfunctions and accidents, where these are known today or shall be applied in the future.
GR990100331A 1999-09-29 1999-09-29 Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses GR1004204B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR99100331 1999-09-29

Publications (2)

Publication Number Publication Date
GR990100331A true GR990100331A (en) 2001-05-31
GR1004204B GR1004204B (en) 2003-09-05

Family

ID=10943929

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990100331A GR1004204B (en) 1999-09-29 1999-09-29 Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses

Country Status (3)

Country Link
AU (1) AU7437900A (en)
GR (1) GR1004204B (en)
WO (1) WO2001023532A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2548643A1 (en) * 2003-04-07 2004-10-28 Neostem, Inc. System capable of treating and defining various diseases using stem cells
US20050042595A1 (en) 2003-08-14 2005-02-24 Martin Haas Banking of multipotent amniotic fetal stem cells
WO2005072790A1 (en) 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Device for directional cooling of biological matter
WO2005072523A2 (en) 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Biological material and methods and solutions for preservation thereof
WO2005120591A1 (en) 2004-06-07 2005-12-22 I.M.T. Interface Multigrad Technology Ltd. Method for sterilization of biological preparations
EP1778007A1 (en) 2004-08-12 2007-05-02 I.M.T. Interface Multigrad Technology Ltd. Method and apparatus for freezing or thawing of a biological material
WO2007015252A2 (en) 2005-08-03 2007-02-08 I.M.T. Interface Multigrad Technology Ltd. Somatic cells for use in cell therapy
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
WO2016187413A1 (en) 2015-05-21 2016-11-24 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333328A2 (en) * 1988-02-17 1989-09-20 Genethics Limited Clinical developments using amniotic cells
WO1997035472A1 (en) * 1996-03-25 1997-10-02 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media
US5879937A (en) * 1994-01-12 1999-03-09 Schering Corporation Cytokine-induced proliferation of amniotic t-cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0815867B1 (en) * 1996-01-23 2003-11-12 Srl, Inc. Cells for treating dementia
AU4860900A (en) * 1999-06-02 2000-12-18 Lifebank Services, L.L.C. Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333328A2 (en) * 1988-02-17 1989-09-20 Genethics Limited Clinical developments using amniotic cells
US5879937A (en) * 1994-01-12 1999-03-09 Schering Corporation Cytokine-induced proliferation of amniotic t-cells
WO1997035472A1 (en) * 1996-03-25 1997-10-02 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ETZIONI A: "Amniocentesis: A case study in the management of 'genetic engineering'.", ETHICS IN SCIENCE AND MEDICINE, vol. 2, no. 1, May 1975 (1975-05-01), pages 13 - 24, XP000923008 *

Also Published As

Publication number Publication date
WO2001023532A1 (en) 2001-04-05
AU7437900A (en) 2001-04-30
GR1004204B (en) 2003-09-05

Similar Documents

Publication Publication Date Title
Verdoes et al. A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages
Southgate et al. Upregulation of basement membrane–degrading metalloproteinase secretion after balloon injury of pig carotid arteries
Chang et al. Effects of calcium silicate endodontic cements on biocompatibility and mineralization-inducing potentials in human dental pulp cells
Kook et al. Involvement of JNK-AP-1 and ERK-NF-κB signaling in tension-stimulated expression of type I collagen and MMP-1 in human periodontal ligament fibroblasts
Carvalho et al. Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction
Casado et al. NK and MSCs crosstalk: the sense of immunomodulation and their sensitivity
GR990100331A (en) Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses
ATE286118T1 (en) APPLICATIONS FOR HUMAN NON-AUTOLOGOUS, MESENCHYMAL STEM CELLS
WO2003042661A8 (en) Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
UA101301C2 (en) Isolated il-23pl9 antibody and use thereof
Cheng et al. Impact of maturational status on the ability of osteoblasts to enhance the hematopoietic function of stem and progenitor cells
CA2338541A1 (en) Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
Kumar et al. Induction of IL-8 (CXCL8) and MCP-1 (CCL2) with oxidative stress and its inhibition with N-acetyl cysteine (NAC) in cell culture model using HK-2 cell
NO20070854L (en) Human monoclonal antibodies to human IL-4.
Gutiérrez-Venegas et al. The flavonoids luteolin and quercetagetin inhibit lipoteichoic acid actions on H9c2 cardiomyocytes
Frick et al. Oral administration of fluoxetine alters the proliferation/apoptosis balance of lymphoma cells and up-regulates T cell immunity in tumor-bearing mice
Charoenpong et al. Mechanical stress induced S100A7 expression in human dental pulp cells to augment osteoclast differentiation
Ivanova et al. The biliprotein C-phycocyanin modulates the early radiation response: A pilot study
Ryba-Stanisławowska et al. IL-33 effect on quantitative changes of CD4+ CD25 high FOXP3+ regulatory T cells in children with type 1 diabetes
KR102167819B1 (en) Pharmaceutical composition for preventing or treating rheumatoid arthritis, comprising nasal inferior turbinate derived mesenchymal stem cell as an active ingredient
Yang et al. Interleukin‐15 inhibits sodium nitroprusside–induced apoptosis of synovial fibroblasts and vascular endothelial cells
Maryam Mirghiasi et al. The effect of Malva neglecta on the reduction of inflammatory agents in patients with osteoarthritis
Rafat et al. Bone marrow CD34 positive cells may be suitable for collection after death
DE60130775D1 (en) STIMULATION OF THE NEUTROPHIL FUNCTION FOR THE TREATMENT OF INFLAMMATORY ENDURANCE DISEASES
Kannan et al. Evaluation of Tualang honey as a supplement to fetal bovine serum in cell culture

Legal Events

Date Code Title Description
PG Patent granted
ML Lapse due to non-payment of fees

Effective date: 20120403